n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with sb 216763 in 1 studies
| Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Studies (sb 216763) | Trials (sb 216763) | Recent Studies (post-2010) (sb 216763) |
|---|---|---|---|---|---|
| 214 | 5 | 58 | 342 | 0 | 225 |
| Protein | Taxonomy | n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine (IC50) | sb 216763 (IC50) |
|---|---|---|---|
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 0.55 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.55 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.55 | |
| Cyclin-A2 | Homo sapiens (human) | 0.269 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.269 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 0.0477 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.0342 | |
| Cyclin-A1 | Homo sapiens (human) | 0.269 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 0.55 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bar-Yehuda, S; Barer, F; Erlanger, A; Fishman, P; Madi, L; Ochaion, A; Ohana, G | 1 |
1 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and sb 216763
| Article | Year |
|---|---|
An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B.
Topics: Adenosine; Animals; beta Catenin; Carcinoma; Cell Division; Cell Line, Tumor; Colonic Neoplasms; Cyclic AMP-Dependent Protein Kinases; Cyclin D1; Cytoskeletal Proteins; Down-Regulation; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Growth Inhibitors; Humans; Indoles; Lithium; Maleimides; Mice; Mice, Nude; NF-kappa B; Proto-Oncogene Proteins c-myc; Purinergic P1 Receptor Agonists; Pyridines; Trans-Activators | 2004 |